Cite

HARVARD Citation

    Radhakrishnan, S. et al. (2019). A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma. Cell transplantation. 28 (12), pp. 1624-1631. [Online]. 
  
Back to record